Following these expansions, NORML classifies Georgia as the 41st medical cannabis state.
Category: Medical Cannabis
“The integration of certain therapeutic cannabis products into the Medicare program further legitimizes the use of marijuana as a medicine, particularly for improving the health-related quality of life of older Americans and seniors.”
“For nearly five years, Alabama patients and their providers have lacked the ability to locally access medically necessary state-approved cannabis products from state-licensed dispensaries. Going forward, let’s hope lawmakers and regulators finally begin putting patients’ needs first.”
NORML worked with union members for nearly two years to assist them in securing the revisions.
“These results affirm the longstanding experiences of patients, many of whom either reduce or eliminate their use of opioids after initiating cannabis therapy because they perceive cannabis to be a safer and more effective alternative.”
The passage of the new rules mark the latest effort by regulators to undermine the state’s 2024 voter-approved medical cannabis access law, which Nebraskans supported by a margin of more than 2 to 1.
“Nearly one-third of migraine sufferers have tried cannabis for symptom management, and patients consistently report that it significantly reduces their pain severity and migraine frequency. These data further affirm patients’ testimonials.”
“Initiation of THC-dominant medicinal cannabis was associated with acute reductions in anxiety and depression, and sustained reductions in overall symptom severity over a 6-month period,” researchers reported.